Last reviewed · How we verify

NCT05210036

HILT and US Therapies in Adhesive Capsulitis

Completed NA Last updated 27 January 2022
What this trial tests

NA trial testing Ultrasound Therapy (US) in Adhesive Capsulitis of Shoulder in 60 participants. Completed in 30 December 2016.

Timeline
15 November 2015
Primary endpoint
15 May 2016
30 December 2016

Quick facts

Lead sponsorBalikesir University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date15 November 2015
Primary completion15 May 2016
Estimated completion30 December 2016

Drugs / interventions tested

Conditions studied

Sponsor

Balikesir University

Who can join

Adults 18 to 70, any sex, with Adhesive Capsulitis of Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Adhesive capsulitis (AC) is a common musculoskeletal disease characterized by pain and limitation of movement in the shoulders of patients. Purpose: This study aimed to assess the effectiveness of short- and long-term therapeutic ultrasound (US) and high-intensity laser therapy (HILT) in the treatment of AC. Methods: A total of 60 patients with AC were randomized into two groups. Group I received US (15 sessions in total) and Group II received HILT (9 sessions in total) for 3 weeks. In addition, all the patients received 15 sessions of physical therapy programs (hot pack, TENS and therapeutic exercises). Assessments were made using VAS-Pain, Shoulder Pain and Disability Index (SPADI) and range of motion (ROM) with goniometer before and at the end of the treatment and in the posttreatment 1st and 6th months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Adhesive Capsulitis of Shoulder

Currently open trials in the same condition.

Other Balikesir University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05210036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing